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http://dx
662Objective: The differential diagnosis of sarcoidosis and tuberculosis is difficult, especially in countries with a
high tuberculosis burden.We hypothesized that sonographic features on endobronchial ultrasonography (EBUS)
would help in differentiating tuberculosis from sarcoidosis. In this study, the endosonographic features of
tuberculosis and sarcoidosis are compared.
Methods: This was a retrospective analysis of prospectively collected data of patients with intrathoracic
lymphadenopathy who underwent EBUS-guided transbronchial needle aspiration (TBNA), and were finally
diagnosed with sarcoidosis or tuberculosis. Sonographic features such as size, shape (round or oval), margin
(distinct or indistinct), echogenicity (heterogeneous or homogeneous), presence or absence of a central hilar
structure, and coagulation necrosis sign were recorded and compared in the 2 groups.
Results: During the study period, 249 EBUS-guided TBNA procedures were performed and a diagnosis of
sarcoidosis (n ¼ 118) or tuberculosis (n ¼ 47) was made in 165 patients. A total of 358 lymph node stations
were examined. Heterogeneous echotexture (53.4% vs 12.6%, P<.001) and coagulation necrosis (26.1% vs
3.3%; P<.001) were significantly higher in tuberculous lymph nodes. A combination of a positive tuberculin
skin test (TST) and either heterogeneous echotexture or coagulation necrosis sign had specificity of 98% and
positive predictive value of 91% for a diagnosis of tuberculosis.
Conclusions: Sonographic features of heterogeneous echotexture or coagulation necrosis in the lymph nodes on
EBUS are fairly specific for tuberculosis. Along with a positive TST, these features strongly favor a diagnosis of
tuberculosis over sarcoidosis. (J Thorac Cardiovasc Surg 2014;148:662-7)Sarcoidosis and tuberculosis are 2 granulomatous disorders
that closely resemble eachother.1Thepresenceof intrathoracic
lymphadenopathy with or without lung infiltrates is a feature
shared by these 2 conditions.2,3 Differentiation between
these 2 granulomatous disorders is mainly dependent on
subtle differences in clinical presentation, microbiological
investigations for Mycobacterium tuberculosis, the presence
or absence of hypersensitivity to purified protein derivative
(PPD), and the microscopic features of the granulomas
identified on cytologic or histologic specimens.4 Blind
transbronchial needle aspiration (TBNA) has been used
traditionally to obtain tissue specimens from intrathoracic
lymph nodes in patients with suspected sarcoidosis and tuber-
culosis.5-7 With the advent of endobronchial ultrasonography
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The Journal of Thoracic and Cardiovascular Surgnodes has significantly improved.8,9 In a recent meta-
analysis, we found EBUS TBNA to be a safe and efficacious
modality in the diagnosis of sarcoidosis.10
The sonographic features of intrathoracic lymph nodes
on EBUS have been found to be useful in differentiating
benign from malignant involvement.11,12 However, the
role of sonographic appearances in the differential
diagnosis of 2 common benign causes of mediastinal
lymphadenopathy (sarcoidosis and tuberculosis) has not
been investigated. Intrathoracic lymph nodes secondary to
tuberculosis demonstrate low-density centers on computed
tomography (CT) of the chest.13 We hypothesized that
EBUS characteristics of mediastinal lymph nodes could
help in differentiating between sarcoidosis and tuberculosis.
In this study, the endosonographic features of tuberculosis
and sarcoidosis are compared and their usefulness in the
differential diagnosis of the 2 clinical mimics is analyzed.METHODS
Patients
This was a retrospective analysis of prospectively collected data of
patients undergoing EBUS TBNA between October 1, 2011, and June 1,
2013. The study protocol was approved by the Ethics Review Committee
and written informed consent was obtained from all patients. Consecutive
patients presenting to the Bronchoscopy Suite of this Institute who
had intrathoracic lymph node enlargement on CT of the chest and wereery c August 2014
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CT ¼ computed tomography
EBB ¼ endobronchial biopsy
EBUS ¼ endobronchial ultrasonography
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OR ¼ odds ratio
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the following were excluded: pregnancy, hypoxemia (pulse oximetric
saturation<90 mm Hg in room air), a deranged coagulation profile, or
failure to provide informed consent. All patients underwent a detailed
clinical evaluation, laboratory tests (complete blood count, coagulation
profile, liver and renal function tests, and angiotensin-converting enzyme
levels), chest radiography, and CT of the chest. Tuberculin skin testing
(TST) with 5 tuberculin units of PPD was performed in all patients and a
value of 10 mm or higher was considered positive.
EBUS TBNA Procedure
EBUS procedures were performed by consultants experienced in the
EBUS technique or by pulmonary fellows under direct supervision of
the consultants. Lymph node stations were classified according to the
International Association for the Study of Lung Cancer map, both on CT
and EBUS.14 The procedure was performed on an outpatient basis under
conscious sedation and analgesia (intravenous midazolam and pentazocine
in doses sufficient to maintain sedation and cough control). Patients were
administered 0.6 mg atropine and 25 mg promethazine intramuscularly
followed by nebulized lignocaine (4% solution) immediately before the
procedure. Topical 10% lignocaine was sprayed over the oropharynx
augmented with 2% lignocaine solution instilled over the vocal cords
and the airways. Monitoring of pulse rate, respiratory rate, pulse oximetric
saturation, and blood pressure was performed throughout the procedure.
The convex probe EBUS scope (BF-UC 180F, Olympus Medical Systems,
Japan) with a 7.5 MHz convex transducer and a compatible endoscopic
ultrasound scanner (EU-ME1, Olympus Medical Systems, Japan) were
used.
EBUS TBNAwas performed in a standard fashion in the supine position
by the oral route using a dedicated, disposable, 21-gauge, Vizishot needle
(NA-201SX-4021, Olympus Medical Systems, Japan) under real-time
sonographic and endoscopic visualization.15 The aspirate was then blown
on to a glass slide by pushing air using a 20-mL syringe. Aspirated material
was also obtained for cell block and mycobacterial cultures (in normal
saline using a mycobacterial growth indicator tube [MGIT]). If a histologic
core was obtained, it was immediately fixed in 10% formalin. A maximum
of 3 aspirates was obtained from each lymph node. In patients withmultiple
enlarged lymph nodes, the largest lymph nodes were sequentially
accessed. On-site cytologic assessment for adequacy of the aspirate was
unavailable.
The decision to perform an endobronchial biopsy (EBB) and transbron-
chial lung biopsy (TBLB) was left to the discretion of the bronchoscopist.
In general, EBB was obtained if there were endobronchial abnormalities or
in patients with clinical suspicion of sarcoidosis. ATBLB was obtained if
therewere any parenchymal abnormalities on the CT scan or in thosewith a
clinical diagnosis of sarcoidosis. A conventional fiber optic bronchoscope
(BF-1T20 or BF-TE2, Olympus, Japan; FB-19TV, Pentax, Japan) alongThe Journal of Thoracic and Cawith standard biopsy forceps (FB19C, Olympus, Japan) were used to
perform the biopsies.
EBUS Image Features of Lymph Nodes
The endobronchial ultrasonographic image classification system
proposed by Fujiwara and colleagues was used to define the lymph
node characteristics.11 The following nodal features were recorded:
(1) size (in millimeters) of the longest dimension (long-axis size) and a
dimension perpendicular to it (short-axis size); (2) shape on visual
inspection (oval or round); (3) margin (distinct or indistinct): when most
of the margin (>50%) was clearly visualized, the lymph node was
classified as distinct; (4) echogenicity (homogeneous or heterogeneous): a
nodewas labeled as heterogeneous if thereweremultiple small areas of vary-
ingechogenicity; (5) presence or absence of a central hilar structure,which is
a linear avascular hyperechoic area in the center of a lymph node; and (6) the
presence or absence of coagulation necrosis defined as the presence of 1 or
more large hypoechoic areaswithin a lymphnodewith absenceof bloodflow
onDoppler (Figure 1).16 The EBUS characteristics of the lymph nodes were
determined and recorded after being agreed on by at least 2 of the operators.
Diagnosis of Sarcoidosis and Tuberculosis
A final diagnosis of sarcoidosis was made on the presence of all of
the following criteria: (1) consistent clinical and radiological presentation;
(2) demonstration of nonnecrotizing granulomas on either EBUS
TBNA, TBLB, or EBB along with negative acid-fast bacilli and
fungal stains; and no growth of mycobacteria on MGIT; (3) clinical and
radiological response after treatment with glucocorticoids.17 A diagnosis
of tuberculosis was based on demonstration of all of the following:
(1) necrotizing granulomatous inflammation or the presence of acid-fast
bacilli on microscopy or a positive culture forM tuberculosis; (2) clinicor-
adiological response to antituberculosis treatment.
Statistical Analysis
Statistical analysis was performed using the commercial statistical
package StatsDirect (version 2.7.2, StatsDirect Ltd, Altrincham, United
Kingdom, 2005. http://www.statsdirect.com). Data were expressed as the
mean  standard deviation (SD) or number with percentage. Differences
between continuous variables in the 2 groups were compared using the
Mann-WhitneyU test; differences between categorical datawere compared
using the c2 test or the Fisher exact test. The performance characteristics of
various endosonographic signs and the TST are presented as sensitivity,
specificity, and predictive values. Agreement for the sonographic
characteristics between lymph node stations in the same patient was
evaluated using the kappa statistic. Multivariate logistic regression analysis
was performed to define factors predicting the diagnosis of tuberculosis.RESULTS
A total of 249 EBUS TBNA procedures were performed
in 245 patients. Four patients underwent the procedure
twice as the first procedure was nondiagnostic. These 4
patients (amounting to 8 procedures) were not considered
for analysis. The mean (SD) age of the remaining 241
patients (107 [44.4%] women) was 44.7 (13.9) years. Of
the 241 patients, a diagnosis of malignancy was made in
26; in 50 patients, no definite diagnosis was made after
EBUS and 6 months of follow-up. A final diagnosis of
sarcoidosis or tuberculosis was made in 165 patients
(118 sarcoidosis and 47 tuberculosis) from the results of
pathologic examination and microbiology. TBLB was per-
formed in 110 of the 165 patients and EBB was performedrdiovascular Surgery c Volume 148, Number 2 663
FIGURE 1. Coagulation necrosis sign (A, arrow) and heterogeneous lymph node echotexture (B, arrowheads) in 2 different patients with a diagnosis of
tuberculosis. Frank pus was aspirated in both patients and cultures grew M tuberculosis.
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granulomas were demonstrated in 33 patients, cultures
were positive for M tuberculosis in 12 patients, and
acid-fast bacilli were demonstrated in 9 patients. The
baseline characteristics of these 165 patients are shown in
Table 1. Patients with tuberculosis were significantly
younger than patients with sarcoidosis and had a higher
prevalence of smoking. A positive TST (induration more
than 10 mm) was seen in a larger proportion of patients
with tuberculosis.TABLE 1. Baseline characteristics of the patients and number of
lymph nodes sampled at various stations
Sarcoidosis
(n ¼ 118)
Tuberculosis
(n ¼ 47)
Total
(n ¼ 165)
P
value
Age, y  SD 43.3  11.7 39.2  13.4 42.2  12.3 .049
Female gender, n (%) 58 (49.2) 24 (51.1) 82 (49.7) .86
Smokers, n (%) 12 (10.2) 15 (31.9) 27 (16.4) .001
Positive TST
(induration 10 mm),
n (%)
4 (3.4) 29 (61.7) 33 (20.0) .001
No. of lymph nodes
sampled according
to stations
4R 85 31 116
4L 8 3 11
7 110 34 144
10R 8 5 13
10L 3 2 5
11R 8 4 12
11L 47 9 56
3P 1 0 1
Short-axis diameter
on EBUS, mm  SD
16.2  4.5 16.5  4.5 16.3  4.5 .64
Short-axis diameter on
CT chest, mm  SD
20.2  7.1 10.9  9.0 20.4  7.6 .55
SD, Standard deviation; TST, tuberculin skin test; EBUS, endobronchial ultrasonog-
raphy; CT, computed tomography.
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The overall size of the lymph nodes on EBUS ranged
from 5 to 38 mm (short axis). There was no difference in
the size of the lymph nodes at various stations measured
on EBUS (or CT chest) in the 2 groups. A total of 358 lymph
node stations (270 sarcoidosis, 88 tuberculosis) were
examined in 165 patients. Among the endosonographic
characteristics (Table 2), a heterogeneous echotexture of
lymph nodes was significantly more common (P< .001)
in tuberculosis (53.4%) than sarcoidosis (12.6%). The
coagulation necrosis sign was seen in 23 (26.1%) lymph
nodes with tuberculosis and 9 (3.3%) of those with
sarcoidosis, showing a statistically significant difference
(P< .001). The odds for diagnosis of tuberculosis were
significantly higher in the presence of heterogeneous
echotexture (odds ratio [OR], 7.96) or coagulation necrosis
sign (OR, 10.26). The agreement for heterogeneous
echotexture and coagulation necrosis between lymph nodes
in the same patient ranged from 0.493 to 0.668 and from
0.381 to 0.658, respectively (k statistic).
Differential Diagnosis
Overall, the finding of heterogeneous echotexture was
observed in 23 (19.5%) and 28 (59.6%) patients with
sarcoidosis and tuberculosis, respectively; the coagulation
necrosis sign was observed in 8 (6.8%) and 16 (34%)
patients with sarcoidosis and tuberculosis, respectively
(Table 3). The specificity of heterogeneous echotexture in
any of the sampled lymph nodes for a diagnosis of tubercu-
losis was 80.5%; the specificity of the coagulation necrosis
sign was 93.2% (Table 3). A combination of a positive
TST and either heterogeneous echotexture or coagulation
necrosis sign had a specificity of 98% and a positive
predictive value of 91% for a diagnosis of tuberculosis
compared with sarcoidosis; the predictive values of the
TST and sonographic characteristics depending on the
prevalence of tuberculosis are depicted in Table 4.ery c August 2014
TABLE 2. Comparison of endosonographic characteristics of lymph
nodes on endobronchial ultrasonography between sarcoidosis and
tuberculosis
Sarcoidosis
(270 lymph
nodes),
n (%)
Tuberculosis
(88 lymph
nodes),
n (%)
Odds ratio
(95%
confidence
intervals)
P
value
Shape
Round 38 (14.1) 17 (19.3) 1.46 (0.78-2.75) .24
Oval 232 (85.9) 71 (80.7)
Margin
Distinct 266 (98.5) 86 (97.7) 1.55 (0.28-8.6) .64
Indistinct 4 (1.5) 2 (2.3)
Echogenicity
Homogeneous 236 (87.4) 41 (46.6) 7.96 (4.58-13.82) <.001
Heterogeneous 34 (12.6) 47 (53.4)
Central hilar
structure
Absent 233 (86.3) 78 (88.6) 0.81 (0.38-1.70) .72
Present 37 (13.7) 10 (11.4)
Coagulation
necrosis sign
Absent 261 (96.7) 65 (73.9) 10.26 (4.53-23.23) <.001
Present 9 (3.3) 23 (26.1)
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echotexture and a positive TST but not the coagulation
necrosis sign were significant predictors of the diagnosis
of tuberculosis (Table 5).
Serious Adverse Events
Two patients developed a pneumothorax after performing
TBLB. One was managed with administration of high flow
oxygen and the other underwent a single-time aspiration.
All patients responded to the management and recovered.
The EBUS TBNA procedure was shortened to only 3 passes
in 1 patient because of excessive coughing. The aspirate in
this patient revealed acid-fast bacilli on microscopic
examination.
DISCUSSION
To the best of our knowledge, this is the first study to
directly compare the EBUS characteristics of lymph nodesTABLE 3. Endobronchial ultrasonography node characteristics for the dif
tuberculosis
Sensitivity,% (95% CI) S
Heterogeneous echotexture 59.6 (44.3-73.6)
Coagulation necrosis sign 34.0 (20.9-49.3)
Heterogeneous echotexture or coagulation
necrosis sign
61.7 (46.4-75.5)
Positive TST (induration 10 mm) 61.7 (46.4-75.5)
Heterogeneous echotexture or coagulation
necrosis sign and positive TST
42.6 (28.3-57.8)
CI, Confidence interval; NPV, negative predictive value; PPV, positive predictive value; T
The Journal of Thoracic and Cain patients with sarcoidosis and tuberculosis. In addition, it
is the largest study to date to describe the endosonographic
characteristics of lymph nodes in patients with either
disease. The results of this study suggest that findings of
heterogeneous echotexture and central necrosis in the
lymph node on EBUS favor a diagnosis of tuberculosis
over sarcoidosis. The positive predictive value for the
diagnosis of tuberculosis is 91% when either of these
findings is combined with a TST.
The recent advent of endoscopic ultrasonographic
techniques (endoscopic ultrasonography and EBUS)
has led to interest in the endosonographic characteristics
of various diseases involving the mediastinal lymph
nodes. The focus has primarily been on differentia-
ting malignant from nonmalignant lymph nodes.11,18
Occasional reports have described findings for sarcoidosis
and tuberculosis.19-22 This is the first study to directly
compare the EBUS characteristics of lymph nodes in
patients with sarcoidosis and tuberculosis. In a recent
study by Imai and colleagues,19 88% of the lymph nodes
in sarcoidosis were homogeneous, similar to our study
(87.4%) and a majority had distinct margins. Most of the
lymph nodes in our study were oval rather than round in
contrast to the study by Imai and colleagues.19 A possible
reason is that we classified the shape of the lymph node
based on visual appearance, whereas Imai and colleagues19
used a long axis to short axis ratio of 2 cm or greater to
define a node as oval. We further believe that measuring
the axis of a lymph node parallel to the airway is difficult,
because it frequently does not fit 1 field of ultrasonic
view. The measurements thus may be erroneous and the
visual impression of shape might be more reliable. We
observed a lower proportion of sarcoidosis lymph
nodes with a central hilar structure than previously
reported for sarcoidosis or benign lymphadenopathy.11,19
This is because we considered a central hilar structure as
a central hyperechoic structure without a central
intranodal vessel.
We found a low sensitivity of the coagulation necrosis
sign (34%) similar to that reported by Rana and
colleagues20 (41%) for the diagnosis of tuberculosis. This
was further reflected in the multivariate analysis where itferential diagnosis of tuberculosis among patients with sarcoidosis and
pecificity,% (95% CI) PPV,% (95% CI) NPV,% (95% CI)
80.5 (72.2-87.2) 54.9 (40.3-68.9) 83.3 (75.2-89.7)
93.2 (87.1-97.0) 66.7 (44.7-84.4) 78.0 (70.3-84.6)
78.8 (70.3-85.8) 53.7 (39.6-67.4) 83.8 (75.6-90.1)
96.6 (91.6-99.1) 87.9 (71.8-96.6) 86.4 (79.3-91.7)
98.3 (94.01-99.8) 90.9 (70.8-98.9) 81.1 (73.7-87.2)
ST, tuberculin skin test.
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TABLE 4. Predictive values of heterogeneous echotexture or
coagulation necrosis sign on endobronchial ultrasonography and
positive tuberculin skin test depending on the prevalence of
tuberculosis
Prevalence,%
Positive predictive
value,% (95% CI)
Negative predictive
value,% (95% CI)
1 20.2 (5.9-84.3) 99.4 (96.7-99.9)
5 56.9 (15.6-91.7) 97.0 (93-99.1)
10 73.6 (36-95.6) 93.9 (88.9-97.1)
20 86.2 (60.1-98) 87.3 (80.8-92.2)
CI, Confidence interval.
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and radiological finding corresponds to the histologic
presence of necrosis. However, the coagulation necrosis
sign has a high specificity (93.2%) for the diagnosis of
tuberculosis. The presence of a heterogeneous lymph
node, on the other hand, had a specificity of 80.5%
for the diagnosis of tuberculosis. Agreement for hetero-
geneous echotexture and coagulation necrosis between
lymph nodes in the same patient was poor suggesting
that as many lymph nodes as possible should be sonograph-
ically evaluated to pick up these findings. Fujiwara and
colleagues11 and others16 have reported the coagulation
necrosis sign as a predictor of malignant involvement,
however in high tuberculosis burden areas, tuberculosis is
an important differential for this sonographic feature.
Although not evaluated in our study, the presence of a
central hilar structure and/or central intranodal vessel may
help in differentiating benign from malignant nodes in
patients with the coagulation necrosis sign when
malignancy is a consideration.11,18,23,24 Our study also
reveals that the size, shape, margin, and presence or
absence of a central hilar structure does not differentiate
between tuberculosis and sarcoidosis. This is in contrast
to the findings of Fritscher-Ravens and colleagues,21 who
observed that tuberculous nodes are significantly smaller
compared with sarcoidosis.
The differential diagnosis of tuberculosis and sarcoidosis
remains a challenge especially in countries with a high
tuberculosis burden.4 Serologic tests as well as qualitative
nucleic acid amplification (NAA) tests for M tuberculosis
do not differentiate tuberculosis from sarcoidosis,25-27
unless quantitative NAA is performed.28 In this regard, theTABLE 5. Multivariate logistic regression analysis on the predictors
of the diagnosis of tuberculosis
Adjusted odds ratio
(95% confidence intervals) P value
Heterogeneous echotexture 3.04 (1.06-8.68) .038
Coagulation necrosis sign 1.93 (0.49-7.58) .349
Positive TST (induration 10 mm) 33.16 (10.05-109.38) .0001
TST, Tuberculin skin test.
666 The Journal of Thoracic and Cardiovascular SurgTST is a good discriminator in differentiating tuberculosis
from sarcoidosis; a positive TST is a strong indicator against
a diagnosis of sarcoidosis.29,30 The results of this study
suggest that sonographic findings of heterogeneous
echotexture or coagulation necrosis sign along with a
positive TST is a stronger discriminator than TST alone,
favoring a diagnosis of tuberculosis (over sarcoidosis)
with a specificity of more than 98%.
Our study has certain limitations. This is a single-center
study conducted in a region with a high prevalence of
tuberculosis. Thus, the conclusions are applicable to similar
settings only, where the differential diagnosis of the 2
conditions is the clinical issue. However, the endosono-
graphic characteristics of either of the 2 diseases can be
generalized. The determination of lymph node characteris-
tics was performed in real time by operators in contrast to
some studies in which the endosonographic images were
saved for analysis of lymph node characteristics at a later
date.11,18 Furthermore, the operators were not blinded to
the clinical presentation and radiological picture of the
patient. In addition, we did not follow any numeric
criterion for defining shape and did not use any software
for determination of echogenicity. This could be a source
of potential subjectivity and bias in recording of the
findings. However, this more closely mimics real-life
clinical situations where operators perform the procedures
without any specific criteria or software. In view of all the
limitations, the model proposed by us needs to be validated
in different centers.
In conclusion, sonographic features of lymph nodes on
EBUS have poor sensitivity but reasonable specificity for
differentiating tuberculosis and sarcoidosis. The finding of
a heterogeneous lymph node echotexture or coagulation
necrosis sign along with a positive TST favors a
diagnosis of tuberculosis over sarcoidosis. This finding
has an important clinical implication in areas with a
high prevalence of tuberculosis, where a decision to start
antituberculosis therapy can be made on the basis of
EBUS findings and a positive TST.References
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